A pragmatic and scalable strategy using mobile technology to promote sustained lifestyle changes to prevent type 2 diabetes in India and the UK: a randomised controlled trial

被引:47
|
作者
Nanditha, Arun [1 ,2 ]
Thomson, Hazel [3 ]
Susairaj, Priscilla [1 ]
Srivanichakorn, Weerachai [3 ,4 ]
Oliver, Nick [3 ]
Godsland, Ian F. [3 ]
Majeed, Azeem [5 ]
Darzi, Ara [6 ]
Satheesh, Krishnamoorthy [1 ]
Simon, Mary [1 ]
Raghavan, Arun [1 ,2 ]
Vinitha, Ramachandran [1 ,2 ]
Snehalatha, Chamukuttan [1 ]
Westgate, Kate [7 ]
Brage, Soren [7 ]
Sharp, Stephen J. [7 ]
Wareham, Nicholas J. [7 ]
Johnston, Desmond G. [3 ]
Ramachandran, Ambady [1 ,2 ]
机构
[1] India Diabet Res Fdn, Chennai, Tamil Nadu, India
[2] Dr A Ramachandrans Diabet Hosp, 110 Anna Salai, Chennai 600032, Tamil Nadu, India
[3] Imperial Coll, Dept Metab Digest & Reprod, Fac Med, London SW7 2AZ, England
[4] Mahidol Univ, Siriraj Hosp, Dept Med, Bangkok, Thailand
[5] Imperial Coll, Sch Publ Hlth, Fac Med, London, England
[6] Imperial Coll, Dept Surg & Canc, Fac Med, London, England
[7] Univ Cambridge, MRC Epidemiol Unit, Sch Clin Med, Inst Metab Sci, Box 285,Cambridge Biomed Campus, Cambridge CB2 0QQ, England
关键词
Behavioural change; Diabetes prevention; Glycosylated haemoglobin A(1c); Lifestyle modification; Mobile technology; Prediabetes; Screening; Short message service; BEHAVIOR-CHANGE; RISK-FACTOR; INTERVENTIONS; DISEASE; SUPPORT; WEIGHT;
D O I
10.1007/s00125-019-05061-y
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims/hypothesis This randomised controlled trial was performed in India and the UK in people with prediabetes to study whether mobile phone short message service (SMS) text messages can be used to motivate and educate people to follow lifestyle modifications, to prevent type 2 diabetes. Methods The study was performed in people with prediabetes (n = 2062; control: n = 1031; intervention: n = 1031) defined by HbA(1c) >= 42 and <= 47 mmol/mol (>= 6.0% and <= 6.4%). Participants were recruited from public and private sector organisations in India (men and women aged 35-55 years) and by the National Health Service (NHS) Health Checks programme in the UK (aged 40-74 years without pre-existing diabetes, cardiovascular disease or kidney disease). Allocation to the study groups was performed using a computer-generated sequence (1:1) in India and by stratified randomisation in permuted blocks in the UK. Investigators in both countries remained blinded throughout the study period. All participants received advice on a healthy lifestyle at baseline. The intervention group in addition received supportive text messages using mobile phone SMS messages 2-3 times per week. Participants were assessed at baseline and at 6, 12 and 24 months. The primary outcome was conversion to type 2 diabetes and secondary outcomes included anthropometry, biochemistry, dietary and physical activity changes, blood pressure and quality of life. Results At the 2 year follow-up (n = 2062; control: n = 1031; intervention: n = 1031), in the intention-to-treat population the HR for development of type 2 diabetes calculated using a discrete-time proportional hazards model was 0.89 (95% CI 0.74, 1.07; p = 0.22). There were no significant differences in the secondary outcomes. Conclusions/interpretation This trial in two countries with varied ethnic and cultural backgrounds showed no significant reduction in the progression to diabetes in 2 years by lifestyle modification using SMS messaging. Funding The study was funded jointly by the Indian Council for Medical Research and the UK Medical Research Council.
引用
收藏
页码:486 / 496
页数:11
相关论文
共 50 条
  • [21] Effects of lifestyle intervention in persons at risk for type 2 diabetes mellitus - results from a randomised, controlled trial
    Nilsen, Vegard
    Bakke, Per S.
    Gallefoss, Frode
    BMC PUBLIC HEALTH, 2011, 11
  • [22] Mobile App for Improved Self-Management of Type 2 Diabetes: Multicenter Pragmatic Randomized Controlled Trial
    Agarwal, Payal
    Mukerji, Geetha
    Desveaux, Laura
    Ivers, Noah M.
    Bhattacharyya, Onil
    Hensel, Jennifer M.
    Shaw, James
    Bouck, Zachary
    Jamieson, Trevor
    Onabajo, Nike
    Cooper, Madeline
    Marani, Husayn
    Jeffs, Lianne
    Bhatia, R. Sacha
    JMIR MHEALTH AND UHEALTH, 2019, 7 (01):
  • [23] Promoting REproductive Planning And REadiness in Diabetes (PREPARED) Study protocol: a clinic-randomised controlled trial testing a technology-based strategy to promote preconception care for women with type 2 diabetes
    Bailey, Stacy C.
    Pack, Allison P.
    Wismer, Guisselle
    Calderon, Norma
    Velazquez, Evelyn
    Batio, Stephanie
    Ekong, Abbey
    Eggleston, Alice
    Wallia, Amisha
    Wolf, Michael S.
    Schauer, Jacob M.
    Tenfelde, Sandi
    Liebovitz, David M.
    Grobman, William A.
    BMJ OPEN, 2023, 13 (11):
  • [24] Community groups or mobile phone messaging to prevent and control type 2 diabetes and intermediate hyperglycaemia in Bangladesh (DMagic): a cluster-randomised controlled trial
    Fottrell, Edward
    Ahmed, Naveed
    Morrison, Joanna
    Kuddus, Abdul
    Shaha, Sanjit Kumer
    King, Carina
    Jennings, Hannah
    Akter, Kohenour
    Nahar, Tasmin
    Haghparast-Bidgoli, Hassan
    Khan, A. K. Azad
    Costello, Anthony
    Azad, Kishwar
    LANCET DIABETES & ENDOCRINOLOGY, 2019, 7 (03): : 200 - 212
  • [25] Effect of a lifestyle intervention on weight change in south Asian individuals in the UK at high risk of type 2 diabetes: a family-cluster randomised controlled trial
    Bhopal, Raj S.
    Douglas, Anne
    Wallia, Sunita
    Forbes, John F.
    Lean, Michael E. J.
    Gill, Jason M. R.
    McKnight, John A.
    Sattar, Naveed
    Sheikh, Aziz
    Wild, Sarah H.
    Tuomilehto, Jaakko
    Sharma, Anu
    Bhopal, Ruby
    Smith, Joel B. E.
    Butcher, Isabella
    Murray, Gordon D.
    LANCET DIABETES & ENDOCRINOLOGY, 2014, 2 (03): : 218 - 227
  • [26] A Community-based Primary Prevention Programme for Type 2 Diabetes in the UK: A Cluster Randomised Controlled Trial
    Davies, Melanie
    Gray, Laura J.
    Goldby, Stephanie
    Hill, Sian
    Yates, Thomas
    Khunti, Kamlesh
    DIABETES, 2015, 64 : A188 - A188
  • [27] Gastric bypass surgery vs intensive lifestyle and medical intervention for type 2 diabetes: the CROSSROADS randomised controlled trial
    Cummings, David E.
    Arterburn, David E.
    Westbrook, Emily O.
    Kuzma, Jessica N.
    Stewart, Skye D.
    Chan, Chun P.
    Bock, Steven N.
    Landers, Jeffrey T.
    Kratz, Mario
    Foster-Schubert, Karen E.
    Flum, David R.
    DIABETOLOGIA, 2016, 59 (05) : 945 - 953
  • [28] Clinical and lifestyle characteristics in newly diagnosed type 2 diabetes: baseline data from the DESMOND randomised controlled trial
    Dallosso, H. M.
    Carey, M. E.
    Davies, M. J.
    Heller, S.
    Khunti, K.
    Skinner, C.
    DIABETOLOGIA, 2008, 51 : S387 - S387
  • [29] Gastric bypass surgery vs intensive lifestyle and medical intervention for type 2 diabetes: the CROSSROADS randomised controlled trial
    David E. Cummings
    David E. Arterburn
    Emily O. Westbrook
    Jessica N. Kuzma
    Skye D. Stewart
    Chun P. Chan
    Steven N. Bock
    Jeffrey T. Landers
    Mario Kratz
    Karen E. Foster-Schubert
    David R. Flum
    Diabetologia, 2016, 59 : 945 - 953
  • [30] Type 2 diabetes remission one year after an intensive lifestyle intervention: a secondary analysis of a randomised controlled trial
    Ried-Larsen, M.
    Johansen, M. Yun
    MacDonald, C.
    Hansen, K.
    Christensen, R.
    Wedell-Neergaard, A. -S.
    Pilmark, N.
    Langberg, H.
    Vaag, A.
    Pedersen, B.
    Karstoft, K.
    DIABETOLOGIA, 2019, 62 : S258 - S258